Literature DB >> 9673230

Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis.

D P Olszyna1, J M Prins, B Buis, S J van Deventer, P Speelman, T van der Poll.   

Abstract

The antiinflammatory cytokine response during urosepsis was determined by measurement of concentrations of soluble tumor necrosis factor receptor (sTNFR) types I and II, interleukin 1 receptor antagonist (IL-1ra), soluble IL-1 receptor type II (sIL-1RII), and interleukin 10 in sera and urine of 30 patients with culture-proven urinary tract infections before and 4, 24, 48, and 72 h after initiation of antibiotic therapy and in 20 healthy individuals. In serum, the levels of sTNFR types I and II, IL-1ra, and IL-10 were higher in patients than in controls. In urine, only sTNFR type I and II levels were elevated in patients. The ratios of concentrations of both types of sTNFR in urine to concentrations in serum were higher in patients than in controls. These findings indicate that during urosepsis, the antiinflammatory cytokine response is generated predominantly at the systemic level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673230      PMCID: PMC108383     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids.

Authors:  I Engelberts; S Stephens; G J Francot; C J van der Linden; W A Buurman
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

Review 2.  Sepsis: a new hypothesis for pathogenesis of the disease process.

Authors:  R C Bone; C J Grodzin; R A Balk
Journal:  Chest       Date:  1997-07       Impact factor: 9.410

3.  Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria.

Authors:  M Benson; U Jodal; W Agace; M Hellström; S Mårild; S Rosberg; M Sjöström; B Wettergren; S Jönsson; C Svanborg
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13.

Authors:  T van der Poll; R de Waal Malefyt; S M Coyle; S F Lowry
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

5.  A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

Authors:  H Engelmann; D Aderka; M Rubinstein; D Rotman; D Wallach
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

6.  Multiple urinary cytokine levels of bacterial cystitis.

Authors:  R Davidoff; R Yamaguchi; G E Leach; E Park; P M Lad
Journal:  J Urol       Date:  1997-05       Impact factor: 7.450

7.  Isolation and characterization of a tumor necrosis factor binding protein from urine.

Authors:  I Olsson; M Lantz; E Nilsson; C Peetre; H Thysell; A Grubb; G Adolf
Journal:  Eur J Haematol       Date:  1989-03       Impact factor: 2.997

8.  Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria.

Authors:  S Hedges; P Anderson; G Lidin-Janson; P de Man; C Svanborg
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

Authors:  D Aderka; H Engelmann; Y Maor; C Brakebusch; D Wallach
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

Review 10.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

View more
  5 in total

1.  Elevated urinary cytokine levels in patients undergoing ileal neobladder replacement compared with sigmoid neobladder replacement.

Authors:  Yuzo Nakano; Hideaki Miyake; Taka-Aki Inoue; Atsushi Takenaka; Isao Hara; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2007-02-20       Impact factor: 2.370

2.  Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer.

Authors:  F Pagès; S Lebel-Binay; A Vieillefond; L Deneux; M Cambillau; O Soubrane; B Debré; D Tardy; J-L Romet Lemonne; J-P Abastado; W-H Fridman; N Thiounn
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

3.  Cause-effect relations between 55 kD soluble TNF receptor concentrations and specific and unspecific symptoms in a patient with mild SLE disease activity: an exploratory time series analysis study.

Authors:  Christian Schubert; Julia Haberkorn; Francisco M Ocaña-Peinado; Paul König; Norbert Sepp; Mirjam Schnapka-Köpf; Dietmar Fuchs
Journal:  BMC Res Notes       Date:  2015-09-21

4.  Soluble Tumor Necrosis Factor-α Receptor 2 in Urine Is a Potential Biomarker for Noninvasive Diagnosis of Malaria During Pregnancy.

Authors:  Samuel Tassi Yunga; Audrey Davidson Thévenon; Rose Gana Fomban Leke; Diane Wallace Taylor
Journal:  Open Forum Infect Dis       Date:  2016-04-26       Impact factor: 3.835

5.  Cytokines and chemokines as biomarkers of community-acquired bacterial infection.

Authors:  Michal Holub; David A Lawrence; Nancy Andersen; Alžběta Davidová; Ondřej Beran; Vilma Marešová; Pavel Chalupa
Journal:  Mediators Inflamm       Date:  2013-04-16       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.